secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2026-06-17T20:55:20+00:00
Accession:  0001104659-26-075204
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dogwood Therapeutics shareholders approve increase in authorized shares at annual meeting
--------------------------------------------------------------------------------

- Stockholders approved amendment to Certificate of Incorporation to increase authorized shares of common and preferred stock with 28,431,012 for, 243,744 against.
- Seven director nominees elected with over 28.6 million votes each; no dissident slate.
- Ratification of Forvis Mazars as auditor for FY 2026 passed with 31,778,192 votes for.
- Advisory vote on executive compensation (Say-on-Pay) approved with 28,662,176 for.
- Board adopts one-year frequency for future Say-on-Pay votes based on stockholder advisory vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000110465926075204/0001104659-26-075204-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000110465926075204/dwtx-20260616x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-075204

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer